Kolexia
Monpoux Fabrice Pédiatrie
Monpoux Fabrice
Pédiatrie
Hôpital De l'Archet
Nice, France
41 Activités
10 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thalassémie Drépanocytose Bêta-Thalassémie Anémie Hémophilie A Hémoglobinopathies Anémie hémolytique auto-immune Syndrome d'hyper-IgM Maladies de von Willebrand

Collaborateurs

Voir plus
Blanche Stéphane
Blanche Stéphane
Hôpital Necker Enfants Malades, Paris, France
Ribeil Antoine-Jean
Ribeil Antoine-Jean
Hôpital Necker Enfants Malades, Paris, France
Cavazzana Marina
Cavazzana Marina
Hôpital Necker Enfants Malades, Paris, France
De Montalembert Mariane
De Montalembert Mariane
Hôpital Necker Enfants Malades, Paris, France

Industries

Voir plus
EXAFIELD
2 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   08 janvier 2024
Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   13 octobre 2023
TRANSHEMO: Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   13 février 2023
A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease: A Phase 1/2 Open Label Study Evaluating the Safety and Efficacy of Gene Therapy of the β-Hemoglobinopathies (Sickle Cell Anemia and β-Thalassemia Major) by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral β-A-T87Q Globin Vector (LentiGlobin BB305 Drug Product)
Essai Clinique (Bluebird)   05 avril 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial.
Nature medicine   24 janvier 2022
Practice changes in the management of major paediatric haemophilia.
Revue de l'infirmiere   19 juillet 2021
EPF: ANRS CO1 EPF Prospective Observational Cohort Study on Mother-to-child Transmission HIV1 and/or HIV2 and Prevention
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   12 avril 2021
Tolerance induction to deferasirox in a child with transfusion-dependent beta thalassemia.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie   26 novembre 2020
Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy
Blood   13 novembre 2019
Severe hyperhomocysteinemia and peripheral neuropathy as side effects of nitrous oxide in two patients with sickle cell disease.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie   17 octobre 2019